Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: J Hypertens. 2012 Jul;30(7):1453–1459. doi: 10.1097/HJH.0b013e328353e807

TABLE 1.

Demographics and clinical variables

IgAN (n = 40) Control (n = 4) P value
Male/female 18/22 2/2 0.9

Age (years) 31 ± 11 45 ± 16 0.1

BMI (kg/m2) 23 ± 5 22 ± 4 0.9

Creatinine clearance (ml/min) 111 ± 33 113 ± 23 0.9

SBP (mmHg)
 Day 117 ± 13 115 ± 19 0.8
 Night 107 ± 13 105 ± 15 0.8
 24 h 113 ± 13 112 ± 18 0.8

DBP (mmHg)
 Day 74 ± 11 79 ± 16 0.4
 Night 67 ± 10 70 ± 15 0.6
 24 h 72 ± 10 76 ± 16 0.4

Night/day ratio of MAP 0.91 ± 0.05 0.89 ± 0.05 0.7

Night/day ratio of UNaV 0.81 ± 0.47 0.80 ± 0.46 0.9

Fractional tubular sodium reabsorption 0.994 ± 0.003 0.994 ± 0.002 0.9

Plasma renin activity (ng/ml per h) 1.7 ± 1.6 0.7 ± 0.6 0.3

Plasma aldosterone concentration (pg/ml) 135 ± 93 37 ± 15 0.08

Plasma angiotensin II (pg/ml) 9.7 ± 5.2 7.5 ± 0.7 0.6

Values are means ± SD. IgAN, IgA nephropathy; MAP, mean arterial pressure (mmHg); UNaV, urinary sodium excretion rate (mmol/h).